“The move comes after Shkreli, its former CEO, was charged on December 17 in federal court with securities fraud related to a hedge fund and another company. Shkreli pleaded not guilty to the charges. Shkreli initially gained notoriety in September when, as the chief executive of Turing Pharmaceuticals, he raised the price of Daraprim— a drug used to treat a dangerous parasitic infection— from $13.50 to $750 per pill. The move generated harsh criticism from prominent politicians, including Hillary Clinton, and spurred a senate investigation into drug pricing.”
http://www.nydailynews.com/news/national/martin-shkreli-company-files-bankruptcy-article-1.2481147
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Iraq still using James McCormick’s fake bomb detectors at checkpoints
US 'told Syria rebels' to seek intervention
French revolutionary rule keeps Paris bakers baking
Amash: Syria strike supporters 'might as well start cleaning out your office'
American-Style Start-Ups Take Root in India
Insurance Executives Meet With Obama Staff on Fixing Health Exchange
Merkel booed as she praises austerity cuts in bailed-out Portugal
Australia’s richest person Gina Rinehart would let prisoners ‘pay for freedom’
"Congestion pricing" part of Mtn. View city plan for Google's growth
6 companies that are the most reliant on government contracts
Granite State 'Bitcom' trio counting on virtual currency Bitcoin
U.S. Regulators Mull Yanking Access To USD As Punishment For Banks
Lawsuit settled accusing former police officer of stalking in uniform
California, Tennessee: More Cities Terminate Traffic Cameras
Jordan says Syrian prime minister has defected with family